journal article·2012-10

The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-κB-related signaling pathways

Hejiang Zhou, Kai Zhao, Wei Li, Na Yang, Ying Liu, Chunying Chen, Taotao Wei

Biomaterials· Volume 33· Issue 29
Publisher page

Abstract

Graphene may have attractive properties for some biomedical applications, but its potential adverse biological effects, in particular, possible modulation of immune responses, require further investigation. Macrophages are one of the most important effector cells of the innate immune system, and play pivotal roles in the response to graphene exposure. We have previously reported that exposure of macrophages to high concentrations of graphene triggers cell death via MAPK- and TGF-related pathways. However, little is known about the influence of exposure to low concentrations of graphene on the function of macrophages. In the present investigation, we demonstrate the biological effects of sub-cytotoxic concentrations of commercial pristine graphene on both primary murine macrophages and immortalized macrophages. Graphene significantly stimulates the secretion of Th1/Th2 cytokines including IL-1α, IL-6, IL-10, TNF-α and GM-CSF as well as chemokines such as MCP-1, MIP-1α, MIP-1β and RANTES, probably by activating TLR-mediated and NF-κB-dependent transcription. Furthermore, these graphene-induced factors alter the morphology of naïve macrophages by remodeling their actin assembly, decreasing their ability to adhere to the extracellular matrix, and attenuating their phagocytosis. This negative feedback of the immune response of macrophages by graphene-induced factors may play an important role in the prevention of their over-activation after graphene exposure. These findings shed light on the interaction of graphene and macrophages in vitro. Further research is needed to systematically assess the biological responses of graphene, both to improve its safety and to contribute to the design of new biological applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Carbon and Quantum Dots Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Electric field effect in atomically thin carbon films10.1126/science.1102896 ↗
2. Graphene in biomedicine: opportunities and challenges10.2217/nnm.10.158 ↗
3. Honeycomb carbon: a review of graphene10.1021/cr900070d ↗
4. Chemically derived graphene oxide: towards large-area thin-film electronics and optoelectronics10.1002/adma.200903689 ↗
5. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice10.1021/nn1024303 ↗
6. Hemocompatibility and macrophage response of pristine and functionalized graphene10.1002/smll.201102393 ↗
7. Impedance based nanotoxicity assessment of graphene nanomaterials at the cellular and tissue level10.1080/00032719.2011.633184 ↗
8. Nano-graphene oxide for cellular imaging and drug delivery10.1007/s12274-008-8021-8 ↗
9. Multi-functional graphene as an in vitro and in vivo imaging probe10.1016/j.biomaterials.2011.12.010 ↗
10. Gold nanoclusters and graphene nanocomposites for drug delivery and imaging of cancer cells10.1002/anie.201105573 ↗
11. An integrated sensing system for detection of DNA using new parallel-motif DNA triplex system and graphene–mesoporous silica–gold nanoparticle hybrids10.1016/j.biomaterials.2011.07.091 ↗
12. Ultrasensitive electrochemical immunoassay for BRCA1 using BMIM.BF-coated SBA-15 as labels and functionalized graphene as enhancer10.1016/j.biomaterials.2010.11.058 ↗
13. Functionalized graphene oxide as a nanocarrier in a multienzyme labeling amplification strategy for ultrasensitive electrochemical immunoassay of phosphorylated p53 (S392)10.1021/ac101715s ↗
14. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs10.1002/smll.200901680 ↗
15. Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery10.1002/smll.201101613 ↗
16. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy10.1021/nl100996u ↗
17. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes10.1016/j.biomaterials.2010.10.030 ↗
18. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide10.1016/j.biomaterials.2011.07.071 ↗
19. Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals10.1021/nn103415x ↗
20. Biocompatible, robust free-standing paper composed of a TWEEN/graphene composite10.1002/adma.200903611 ↗
21. The promotion of neurite sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates10.1016/j.biomaterials.2011.08.065 ↗
22. A graphene-based platform for induced pluripotent stem cells culture and differentiation10.1016/j.biomaterials.2011.09.071 ↗
23. Impact of nanoparticles on the immune system10.1166/jbn.2011.1264 ↗
24. Nanotoxicology: are carbon nanotubes safe?10.1038/nnano.2008.77 ↗
25. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells10.1021/nn1007176 ↗
26. Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis10.1021/nn900912n ↗
27. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils10.1038/ni.2109 ↗
28. Development of monocytes, macrophages, and dendritic cells10.1126/science.1178331 ↗
29. Biodistribution and ultrastructural localization of single-walled carbon nanohorns determined in vivo with embedded Gd2O3 labels10.1021/nn9004846 ↗
30. Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment10.1021/nl300027p ↗
31. The role of the lateral dimension of graphene oxide in the regulation of cellular responses10.1016/j.biomaterials.2012.02.021 ↗
32. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties10.1021/nn204229f ↗
33. The mononuclear phagocyte system10.1016/j.coi.2005.11.008 ↗
34. The many faces of macrophage activation10.1189/jlb.0602325 ↗
35. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways10.1016/j.biomaterials.2011.09.091 ↗
36. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity10.1016/j.biomaterials.2009.04.001 ↗
37. Effect of melatonin on the generation of nitric oxide in murine macrophages10.1016/j.ejphar.2004.08.015 ↗
38. ESeroS-GS modulates lipopolysaccharide-induced macrophage activation by impairing the assembly of TLR-4 complexes in lipid rafts10.1016/j.bbamcr.2011.01.019 ↗
39. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB10.1189/jlb.0408238 ↗
40. Ultrafine particles cause cytoskeletal dysfunctions in macrophages10.1006/taap.2002.9430 ↗
41. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions10.1128/CMR.15.3.414-429.2002 ↗
42. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology10.1042/BJ20040544 ↗
43. Signaling to NF-kappaB by Toll-like receptors10.1016/j.molmed.2007.09.002 ↗
44. Innate immunity to pathogens: diversity in receptors for microbial recognition10.1111/j.1600-065X.2008.00739.x ↗
45. Pathogen recognition and innate immunity10.1016/j.cell.2006.02.015 ↗
46. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors10.1038/ni.1863 ↗
47. The induction of innate and adaptive immunity by biodegradable poly(gamma-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway10.1016/j.biomaterials.2011.03.052 ↗
48. Podosomes: adhesion hot-spots of invasive cells10.1016/S0962-8924(03)00128-4 ↗
49. Macrophage podosomes assemble at the leading lamella by growth and fragmentation10.1083/jcb.200212037 ↗
50. Contribution of actin to the structure of the cytoplasmic matrix10.1083/jcb.99.1.15s ↗